These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
127 related articles for article (PubMed ID: 38063155)
1. Disproportionate Sociodemographic Effects of Suspended Breast Cancer Screening During the COVID-19 Pandemic. Narvacan K; Patlas MN Can Assoc Radiol J; 2024 May; 75(2):218-219. PubMed ID: 38063155 [No Abstract] [Full Text] [Related]
2. Evaluation of the Association Between Sociodemographic Status and Breast Screening Volumes During the COVID-19 Pandemic in a Provincial, Population-Based Organized Breast Screening Program. Bentley H; Raveinthiranathan N; Mar C; Tang T; Regier DA; Chi K; Simkin J; Kellow Z; Yong-Hing CJ; Woods RR Can Assoc Radiol J; 2024 May; 75(2):253-260. PubMed ID: 37619596 [TBL] [Abstract][Full Text] [Related]
3. Evaluating Trends in Screening Mammography Volumes at a Tertiary Academic Institution During the COVID-19 Pandemic. Ambinder EB; Carson KA; Nguyen DL; Cha E; Peshtani A; Myers KS; Oluyemi ET J Am Coll Radiol; 2024 Jul; 21(7):1067-1071. PubMed ID: 38378103 [No Abstract] [Full Text] [Related]
4. Barriers to breast cancer screening are worsened amidst COVID-19 pandemic: A review. Tsapatsaris A; Babagbemi K; Reichman MB Clin Imaging; 2022 Feb; 82():224-227. PubMed ID: 34896935 [TBL] [Abstract][Full Text] [Related]
5. Impact of Covid-19 on Breast Cancer Screening. Stevanato KP; Pelloso FC; Borghesan DHP; Ribeiro HF; Carvalho MDB; Pelloso SM Asian Pac J Cancer Prev; 2024 Aug; 25(8):2703-2710. PubMed ID: 39205568 [TBL] [Abstract][Full Text] [Related]
6. Hindsight is 2020: Understanding the Impact of the COVID-19 Pandemic on a Provincial Population-Based Breast Screening Program. Bentley H; Woods R; Mar C; Tang T; Raveinthiranathan N; Kellow Z; Yong-Hing CJ Can Assoc Radiol J; 2022 Aug; 73(3):589-591. PubMed ID: 34758655 [No Abstract] [Full Text] [Related]
7. Assessment of a Risk-Based Approach for Triaging Mammography Examinations During Periods of Reduced Capacity. Miglioretti DL; Bissell MCS; Kerlikowske K; Buist DSM; Cummings SR; Henderson LM; Onega T; O'Meara ES; Rauscher GH; Sprague BL; Tosteson ANA; Wernli KJ; Lee JM; Lee CI JAMA Netw Open; 2021 Mar; 4(3):e211974. PubMed ID: 33764423 [TBL] [Abstract][Full Text] [Related]
8. Breast Cancer Screening and Optimizing Recommendations. Lancaster RB; Gulla S; De Los Santos J; Umphrey H Semin Roentgenol; 2018 Oct; 53(4):280-293. PubMed ID: 30449346 [No Abstract] [Full Text] [Related]
9. Diagnostic interval for non-screening patients undergoing mammography during the COVID-19 pandemic. Crivellaro P; Tafur M; George R; Muradali D Eur Radiol; 2022 Jan; 32(1):613-620. PubMed ID: 34143286 [TBL] [Abstract][Full Text] [Related]
10. Racial and socioeconomic inequities in breast cancer screening before and during the COVID-19 pandemic: analysis of two cohorts of women 50 years + . Monsivais P; Amiri S; Robison J; Pflugeisen C; Kordas G; Amram O Breast Cancer; 2022 Jul; 29(4):740-746. PubMed ID: 35366175 [TBL] [Abstract][Full Text] [Related]
11. Breast Cancer Screening During the COVID-19 Pandemic in the United States: Results From Real-World Health Records Data. Chung A; Chen Q; Curry W; Felix T; Tuan WJ Ann Fam Med; 2024; 22(3):208-214. PubMed ID: 38806260 [TBL] [Abstract][Full Text] [Related]
12. Effects of the COVID-19 pandemic on breast cancer screening in Taiwan. Tsai HY; Chang YL; Shen CT; Chung WS; Tsai HJ; Chen FM Breast; 2020 Dec; 54():52-55. PubMed ID: 32919172 [TBL] [Abstract][Full Text] [Related]
13. Impact of the COVID-19 pandemic on breast cancer screening volumes and patient screening behaviors. Miller MM; Meneveau MO; Rochman CM; Schroen AT; Lattimore CM; Gaspard PA; Cubbage RS; Showalter SL Breast Cancer Res Treat; 2021 Aug; 189(1):237-246. PubMed ID: 34032985 [TBL] [Abstract][Full Text] [Related]
14. The Impact of the COVID-19 Pandemic on Breast Imaging. Freer PE Radiol Clin North Am; 2021 Jan; 59(1):1-11. PubMed ID: 33222992 [TBL] [Abstract][Full Text] [Related]
15. Trends in breast and prostate cancer screening and diagnostic procedures during the COVID-19 pandemic in central Massachusetts. Epstein MM; Sundaresan D; Fair M; Fouayzi H; Warner ET; Garber LD; Gurwitz JH; Field TS Cancer Causes Control; 2022 Oct; 33(10):1313-1323. PubMed ID: 35933572 [TBL] [Abstract][Full Text] [Related]
16. Evidence to Support Screening Women in Their 40s. Ray KM; Price ER; Joe BN Radiol Clin North Am; 2017 May; 55(3):429-439. PubMed ID: 28411671 [TBL] [Abstract][Full Text] [Related]
17. Disparities in Same-Day Diagnostic Imaging in Breast Cancer Screening: Impact of an Immediate-Read Screening Mammography Program Implemented During the COVID-19 Pandemic. Dontchos BN; Achibiri J; Mercaldo SF; Wang GX; Lamb LR; Miles RC; Narayan AK; Lehman CD AJR Am J Roentgenol; 2022 Feb; 218(2):270-278. PubMed ID: 34494449 [No Abstract] [Full Text] [Related]
18. How best to determine the mortality benefit from screening mammography: dueling results and methodologies from Canada. Harris RP J Natl Cancer Inst; 2014 Nov; 106(11):. PubMed ID: 25274580 [No Abstract] [Full Text] [Related]
19. Examining the Association Between the COVID-19 Pandemic and the Rate of Diagnostic Tests for Breast, Cervical, and Colorectal Cancer in Manitoba, Canada. Decker KM; Musto G; Bucher O; Czaykowski P; Hebbard P; Kim JO; Singh H; Thiessen M; Feely A; Galloway K; Lambert P Technol Cancer Res Treat; 2024; 23():15330338241263616. PubMed ID: 39053019 [No Abstract] [Full Text] [Related]
20. Examining the impact of COVID-19 disruptions on population-based breast cancer screening in Ireland. O'Driscoll J; Mooney T; Kearney P; Williams Y; Lynch S; Connors A; Larke A; McNally S; O'Doherty A; Murphy L; Bennett KE; Fitzpatrick P; Mullooly M; Flanagan F J Med Screen; 2024 Sep; 31(3):182-190. PubMed ID: 38509806 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]